Gabapentin
Pre-clinicalUNKNOWN 0 watching 0 views this week๐ค Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pruritus
Conditions
Pruritus, Uremia
Trial Timeline
Oct 1, 2005 โ Mar 1, 2006
NCT ID
NCT00577967About Gabapentin
Gabapentin is a pre-clinical stage product being developed by Pfizer for Pruritus. The current trial status is unknown. This product is registered under clinical trial identifier NCT00577967. Target conditions include Pruritus, Uremia.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (10)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01441401 | Pre-clinical | Completed |
| NCT00620555 | Phase 3 | Completed |
| NCT00603473 | Phase 3 | Completed |
| NCT00567268 | Pre-clinical | Completed |
| NCT00659100 | Phase 3 | Completed |
| NCT00577967 | Pre-clinical | UNKNOWN |
| NCT00533455 | Phase 3 | Terminated |
| NCT00137735 | Phase 3 | Completed |
| NCT00644748 | Approved | Completed |
| NCT00169013 | Approved | Completed |
Competing Products
20 competing products in Pruritus